It's been much too long (two years now!) since we had Chris on Episode #093 of the PricePlow Podcast, but since he's come on board, they've had one success after another
Arnott C, Huang Y, Neuen BL, et al
This approach helps more patients stay on the treatment, experience the full health benefits of these medications, and make real progress in reducing obesity and overweight rates in the United States. According to Noom, members on GLP-1s log more meals, weigh in more frequently and report more physical activity by their second month than those not on medication
Available from: Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P
The food and beverage industry is on the brink of an exciting transformation, driven by a surge in innovative GLP-1 drugs used for weight loss and blood sugar regulation treatments
And remember: Avoid any telehealth company falsely claiming that compounded drugs have been approved by the FDA